Adaptive Immunity
Products Related to Adaptive Immunity(210)
- GC524462-Nonylquinolin-4(1H)-one-d4Purity: >99.00%
An internal standard for the quantification of 2-nonylquinolin-4(1H)-one
- GC60622BAY 2416964CAS: 2242464-44-2Purity: >98.00%
BAY 2416964 is a potent and orally active inhibitor targeting aryl hydrocarbon receptor (AhR) with IC 50 value of 341nM.
- GC90243Myelin Basic Protein (human, bovine, rat) (trifluoroacetate salt)Purity: >95.00%
An encephalitogenic peptide
- GC90508Ala-D-γ-Glu-Lys-D-Ala-D-Ala (trifluoroacetate salt)CAS: 62182-55-2Purity: >98.00%
A peptidoglycan pentapeptide
- GC90631LL-37 (human) (scrambled) (trifluoroacetate salt)Purity: >95.00%
A negative control for LL-37 (human)
- GC907441,2-Dioleoyl-3(R)-trimethylammoniumpropane (chloride)CAS: 328250-28-8Purity: >95.00%
A cationic lipid
- GC909341,2,3,6,7,8-Hexachlorodibenzo-p-dioxinCAS: 57653-85-7Purity: >98.00%
A polychlorinated dibenzodioxin
- GC909371,2,3,4,7,8,9-HeptachlorodibenzofuranCAS: 55673-89-7Purity: >95.00%
A dioxin-like polychlorinated dibenzofuran
- GC909381,2,3,4,7,8-HexachlorodibenzofuranCAS: 70648-26-9Purity: >90.00%
A dioxin-like polychlorinated dibenzofuran
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC52446 | 2-Nonylquinolin-4(1H)-one-d4 | - | >99.00% | |
An internal standard for the quantification of 2-nonylquinolin-4(1H)-one | ||||
| GC56074 | DSG-PEG 2000 | 308805-39-2 | >99.00% | |
| GC60182 | GSK046 | 2474876-09-8 | >98.00% | |
GSK046 (iBET-BD2) is a potent, selective and orally active BD2 bromodomain inhibitor of the BET proteins, with IC50s of 264 nM (BRD2 BD2), 98 nM (BRD3 BD2), 49 nM (BRD4 BD2) and 214 nM (BRDT BD2), respectively. | ||||
| GC60622 | BAY 2416964 | 2242464-44-2 | >98.00% | |
BAY 2416964 is a potent and orally active inhibitor targeting aryl hydrocarbon receptor (AhR) with IC 50 value of 341nM. | ||||
| GC60628 | BD750 | 892686-59-8 | >99.50% | |
BD750, an effective immunosuppressant and a JAK3/STAT5 inhibitor, inhibits IL-2-induced JAK3/STAT5-dependent T cell proliferation, with IC50 values of 1.5 μM and 1.1 μM in mouse and human T cells, respectively. | ||||
| GC61367 | VAF347 | 574759-62-9 | >99.50% | |
VAF347 is a cell permeable and highly affinity aryl hydrocarbon receptor (AhR) agonist and induces AhR signaling. | ||||
| GC71273 | C12-TLRa | - | >99.00% | |
C12-TLRa is an adjuvant lipidoid. | ||||
| GC90243 | Myelin Basic Protein (human, bovine, rat) (trifluoroacetate salt) | - | >95.00% | |
An encephalitogenic peptide | ||||
| GC90363 | 10(11)-Cl-BBQ | - | >95.00% | |
A mixture that acts as an AhR agonist | ||||
| GC90508 | Ala-D-γ-Glu-Lys-D-Ala-D-Ala (trifluoroacetate salt) | 62182-55-2 | >98.00% | |
A peptidoglycan pentapeptide | ||||
| GC90549 | 5-Aminoimidazole-4-carboxamide (hydrate) | - | >95.00% | |
A synthetic precursor | ||||
| GC90631 | LL-37 (human) (scrambled) (trifluoroacetate salt) | - | >95.00% | |
A negative control for LL-37 (human) | ||||
| GC90672 | L202 | 2170488-92-1 | >95.00% | |
An ionizable cationic lipid | ||||
| GC90701 | CAY10795 | 2241676-74-2 | >98.00% | |
A 15-PGDH inhibitor | ||||
| GC90705 | BSP-16 | 2727249-47-8 | >98.00% | |
A STING agonist | ||||
| GC90710 | CAY10723 (hydrochloride) | - | >95.00% | |
A PAD2 inhibitor | ||||
| GC90744 | 1,2-Dioleoyl-3(R)-trimethylammoniumpropane (chloride) | 328250-28-8 | >95.00% | |
A cationic lipid | ||||
| GC90772 | YK-009 | 2761458-86-8 | >95.00% | |
An ionizable cationic lipid | ||||
| GC90813 | 2'-deoxy NAD+ (sodium salt) | 1514900-83-4 | >95.00% | |
A TRPM2 agonist | ||||
| GC90912 | DNCA | 2226561-66-4 | >95.00% | |
A neutral lipid | ||||
| GC90932 | Lipid 14 | 2430034-05-0 | >95.00% | |
An ionizable cationic amino lipid | ||||
| GC90934 | 1,2,3,6,7,8-Hexachlorodibenzo-p-dioxin | 57653-85-7 | >98.00% | |
A polychlorinated dibenzodioxin | ||||
| GC90937 | 1,2,3,4,7,8,9-Heptachlorodibenzofuran | 55673-89-7 | >95.00% | |
A dioxin-like polychlorinated dibenzofuran | ||||
| GC90938 | 1,2,3,4,7,8-Hexachlorodibenzofuran | 70648-26-9 | >90.00% | |
A dioxin-like polychlorinated dibenzofuran | ||||